You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Exercise Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 14, 2026
Exercise
Calculated transaction value
$1.12M
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 13, 2026
Public filing date
Oct 14, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$543.4
Oct 13, 2026
First close after public filing
$541.51
Oct 15, 2026
Return after filing · so far
+10.0%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,500 shares @ $117.76
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001106578-26-000163
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.3M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $88.09K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $812.48K |
| United Therapeutics Corp UTHR Current | Exercise | Oct 13, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Exercise | Oct 13, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $1.27M |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $793.46K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $346.82K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $822.1K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $344.91K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $382.84K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $275.83K |
| United Therapeutics Corp UTHR | Sale | Oct 13, 2026 | $44.12K |